Health Capital Helsinki and BioInnovation Institute (BII) are arranging an online event called
Funding journey: From research to commercialization aimed at Health & Life Science researchers and startups.
The event is a great opportunity to find out about the programs, funding and collaboration opportunities provided by key players in the Nordic life science ecosystem: The Novo Nordisk Foundation, BioInnovation Institute and EIR Ventures. In addition, the participants will have a unique possibility to book 1:1 meetings with representatives of these institutions.
Time: 27 January 2022, 11.00–15.00 Helsinki, EET
Content: 2 hours of presentations, 2 hours reserved for 1:1 meetings
This event is free of charge but requires registration. Notice that you need to register for both parts separately.
PART 1: Presentations
11.00-11.15: Welcome and introduction from Juha Paakkola, Director at Health Capital Helsinki
11.15-11.35: Presentation of NNF, Karin Hultman, Scientific Manager, Innovation at the Novo Nordisk Foundation: Novo Nordisk Foundation Innovation Grants
11.35-11.55: Presentation of BII, Giles Dudley, Director at BioInnovation Institute: Bridging the funding gap in the innovation ecosystem
– 5-minutes’ break –
12.00-12.20: Presentation of EIR Ventures, Stephan Christgau, Founding Partner at EIR Ventures: The role of Venture Capital in Commercializing Life Science Innovation
12.20-12.40: Case story from a BII startup: Stefano TwelveBio
PART 2: 1:1 meetings
13.00-15.00: Participants can pre-book meetings with the presenters prior to the event via Tavata.
Create a profile for Tavata matchmaking platform and start booking meetings. Go to https://app.tavata.events/signup and join the event with code: GRUA (note: capital letters).
Source: Health Capital Helsinki